CVS Health Q1 2025 Financial Highlights

Revenue Growth: CVS Health Corporation announced a 7% annual increase in revenue for the first quarter of 2025, reaching $94.6 billion. However, this figure fell short of market expectations.

Net Income: The company reported a net income of $1.78 billion, a significant rise from $1.12 billion in the same period last year. Diluted earnings per share (EPS) also saw an uptick to $1.41, compared to $0.88 in 2024.

Revised Full-Year Guidance

CVS Health has adjusted its full-year 2025 cash flow from operations guidance downward by $500 million to $7.0 billion. The GAAP diluted EPS guidance is now projected to be between $4.23 and $4.43.

Leadership's Perspective

"Our dedicated team at CVS Health has achieved positive outcomes across all segments, thanks to our unwavering commitment to our customers. We are proud to serve 185 million consumers, advancing our mission to create a healthier world," stated President and CEO David Joyner.

Market Reaction: Following the announcement, CVS shares experienced a 4.79% increase in premarket trading, reaching $71.5 per share.